This is not the most recent version of the article. View current version (31 MAY 2013)

Intervention Protocol

Percutaneous ethanol injection for liver metastases

  1. Robert P Riemsma1,*,
  2. Malgorzata Bala2,
  3. Robert Wolff1,
  4. Jos Kleijnen1

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 8 SEP 2010

Assessed as up-to-date: 9 MAY 2010

DOI: 10.1002/14651858.CD008717


How to Cite

Riemsma RP, Bala M, Wolff R, Kleijnen J. Percutaneous ethanol injection for liver metastases (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD008717. DOI: 10.1002/14651858.CD008717.

Author Information

  1. 1

    Kleijnen Systematic Reviews Ltd, York, UK

  2. 2

    Jagiellonian University Medical College, 2nd Department of Internal Medicine, Krakow, Poland

*Robert P Riemsma, Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD, UK. rob@systematic-reviews.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 SEP 2010

SEARCH

This is not the most recent version of the article. View current version (31 MAY 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To study the beneficial and harmful effects of percutaneous ethanol injection compared with no intervention, other ablation methods, or systemic treatments in patients with liver metastases.